Generic Name: Olmesartan Medoxomil 20mg
Manufacturer/Distributor: Square Pharmaceuticals Ltd.
🛒 How to order this item?
100% Genuine Products, Guaranteed
Safe & Secure Payments, Always
Fast, Secure & Efficient Delivery
Proper Packaging
Show More
Indications
Olmecar 20 is a medication used to treat heart failure and high blood pressure. Blood pressure reduction aids in reducing the risk of future heart attacks and strokes. Using this medication can help diabetic patients maintain kidney function.
Pharmacology
The essential vasoactive hormone of the renin-angiotensin system and a key player in the pathophysiology of hypertension, angiotensin-II is formed from angiotensin-I in a reaction catalyzed by angiotensin-converting chemical (Expert). It also stimulates the adrenal cortex's release of aldosterone. By specifically preventing angiotensin-II from binding to the AT 1 receptor, which is present in many tissues (including vascular smooth muscle and the adrenal organ), olmesartan blocks the effects of angiotensin-II that cause the release of aldosterone and vasoconstriction. Olmesartan may be a reversible and competitive inhibitor of the AT 1 receptor, according to in-vitro binding studies. Expert (kinase-I, the protein that converts angiotensin-I to angiotensin-II and corrupts bradykinin) is not suppressed by olmesartan.
Dosage & Administration
Interaction
The risk of hyperkalemia is increased by ACE inhibitors, K-sparing diuretics, K salts, K supplements, and medications that could raise serum K levels (e.g. ciclosporin, eplerenone). BP-lowering effects from other antihypertensives may be enhanced. NSAIDs may lower glomerular filtration, which can lead to acute renal failure. Lithium toxicity and serum concentrations may rise.
Contraindications
Olmesartan is contraindicated in patients who are extremely touchy with any component of this item.
Side Effects
Pregnancy & Lactation
Pregnancy: If you find out you're pregnant, stop using this product as soon as you can. Drugs that act directly on the renin-angiotensin system during the first and third trimesters of pregnancy can be harmful and even pass to the developing fetus.
Nursing Mothers: Olmesartan is discharged at low concentrations in the drain of lactating rats, but it is unknown if Olmesartan is excreted in human waste. Given the potential for negative effects on the nursing newborn child, a decision should be made regarding whether to stop the sedate or stop nursing, taking into account the significance of the sedate to the mother.
Precautions & Warnings
Changes in renal function may be anticipated in susceptible patients receiving olmesartan medoxomil due to the framework's restraint. Treatment with angiotensin-converting protein inhibitors and angiotensin receptor antagonists has been associated with oliguria and/or dynamic azotemia and (rarely) with intense renal disappointment and/or passing in patients whose renal function may depend on the action of the renin-angiotensin-aldosterone framework (e.g. patients with severe congestive heart failure). Similar results could be anticipated in patients receiving olmesartan medoxomil.
Storage Conditions
Protect from light and moisture by storing in a cool, dry location. Keep out of children's reach.
Disclaimer:
ePharma sole intention is to ensure that its consumers get proper
information as musch as possible. Although we do not guarantee the
accuracy and the completeness of the information that provided and
here information is for informational purposes only.
The information contained herein should NOT be used as a substitute
for the advice of a qualified physician. This may not cover
everything about particular health conditions,
lab tests, medicines, all possible side effects, drug interactions,
warnings, alerts, etc. Please consult your healthcare professional
and discuss all your queries related to any disease or medicine. We
intend to support, not replace, the doctor-patient relationship.